Absci Corp reports results for the quarter ended in June - Earnings Summary

* Absci Corp  ABSI.OQ  reported a quarterly adjusted loss
of 22
cents​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -45
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 19 cents per share. Wall Street expected
results to range from -24 cents to -17 cents per share.
    * Revenue fell 62.3% to $1.27 million from a year ago;
analysts
expected $1.91 million. 
    * Absci Corp's reported EPS for the quarter was a loss of 22
cents​.
    * The company reported a quarterly loss of $24.75 million.
    * Absci Corp shares had risen by 26.0% this quarter and
lost 7.6%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Absci Corp is
$7.00 
This summary was machine generated from LSEG data August 15 at
04:38 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.19          -0.22          Missed
 Mar. 31 2024      -0.21          -0.22          Missed
 Dec. 31 2023      -0.25          -0.25          Met
 Sep. 30 2023      -0.23          -0.24          Missed

Recent news on AbSci

See all news